| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.003 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.17 | 0.004 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |